Weeks 4-6 Trials titrated to 2mg
Two large 72-week clinical trials that evaluated terzepatide in individuals who were overweight or obese found that by the end of the study, people who also dieted and exercised reported statistically significant weight loss compared to those who took the placebo
Longato E, Di Camillo B, Sparacino G, Tramontan L, Avogaro A, Fadini GP
Headaches: Reported at rates slightly above placebo, headaches can often be attributed to dehydration or rapid dietary changes rather than direct pharmacological effects
A professional Retatrutide wholesale supplier helps organizations maintain procurement efficiency through dependable inventory availability and responsive support
Keeping a simple injection diary or using a body diagram can help track rotation